TAR-200 is a miniature, pretzel-shaped drug-device duo containing a chemotherapy drug, gemcitabine, which is inserted into the...
bladder
Contact: Eileen Teves, 210-450-7239, [email protected] SAN ANTONIO, June 27, 2025 – In a multi-institutional study published in Science Direct, researchers...
CG Oncology (NASDAQ: CGON), a late-stage clinical biopharmaceutical company specializing in bladder...
Your support helps us to tell the storyFrom reproductive rights to climate change to Big Tech, The Independent is on...
Petros Grivas, MD, PhD, clinical director of the genitourinary cancers program at University of Washington Medicine and professor at Fred...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)...
